Although treatment with anti-NGF antibodies is still undergoing clinical
trials, at least one such trial has strongly supported its efficacy for
treatment of refractory osteoarthritis pain and low back pain However, there have been no previous studies of the effect of antiNGF
antibody administration on muscle injury.